Found: 35
Select item for more details and to access through your institution.
Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1793, doi. 10.1177/10781552231185855
- By:
- Publication type:
- Article
Nivolumab for newly and recurrent glioblastoma multiforme treatment: A systematic review and meta-analysis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1736, doi. 10.1177/10781552231190104
- By:
- Publication type:
- Article
The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1725, doi. 10.1177/10781552231189864
- By:
- Publication type:
- Article
Nivolumab-induced immune-related neutropenia in a renal cell carcinoma patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1797, doi. 10.1177/10781552231186748
- By:
- Publication type:
- Article
Drug extravasation with Enfortumab vedotin.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1789, doi. 10.1177/10781552231185505
- By:
- Publication type:
- Article
Analysis of adverse events leading to dose reduction/interruption of lenvatinib treatment in patients with Child-Pugh B unresectable hepatocellular carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1637, doi. 10.1177/10781552221145475
- By:
- Publication type:
- Article
Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1785, doi. 10.1177/10781552231185153
- By:
- Publication type:
- Article
Knowledge and practices about safe handling regarding the risk of exposure to antineoplastic drugs for caregivers in compounding units and in operating rooms performing HIPEC/PIPAC.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1628, doi. 10.1177/10781552221144303
- By:
- Publication type:
- Article
Anxiety exacerbation in a patient with chronic myeloid leukemia receiving dasatinib and venlafaxine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1762, doi. 10.1177/10781552231181333
- By:
- Publication type:
- Article
Atezolizumab-associated myositis in a patient with unresectable hepatocellular carcinoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1757, doi. 10.1177/10781552231180876
- By:
- Publication type:
- Article
Processes and perceptions of chemotherapy supply chain in Ethiopia: A mixed-method study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1555, doi. 10.1177/10781552221134254
- By:
- Publication type:
- Article
Colonic mucosal diffuse congestion associated with Osimertinib.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1781, doi. 10.1177/10781552231184182
- By:
- Publication type:
- Article
Comprehensive pharmacological geriatric assessment compared to usual care in an older adult with cancer in the absence of polypharmacy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1776, doi. 10.1177/10781552231182936
- By:
- Publication type:
- Article
Gemcitabine-associated digital necrosis in metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1770, doi. 10.1177/10781552231182356
- By:
- Publication type:
- Article
Unusual stroke-like symptoms with oxaliplatin use.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1766, doi. 10.1177/10781552231181525
- By:
- Publication type:
- Article
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1748, doi. 10.1177/10781552231180598
- By:
- Publication type:
- Article
Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1715, doi. 10.1177/10781552221150935
- By:
- Publication type:
- Article
Myocardial bridge in a patient with castration-resistant metastatic prostate cancer treated with enzalutamide.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1754, doi. 10.1177/10781552231180599
- By:
- Publication type:
- Article
Assessment of patients' knowledge of their treatment with capecitabine at the National Institute of Oncology in Rabat.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1708, doi. 10.1177/10781552221150802
- By:
- Publication type:
- Article
Cost comparison of filgrastim versus pegfilgrastim and pegfilgrastim biosimilars for inpatient prophylaxis of febrile neutropenia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1695, doi. 10.1177/10781552221147658
- By:
- Publication type:
- Article
Implications of a technician-led pharmacy service on a day case unit in a tertiary oncology centre.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1702, doi. 10.1177/10781552221147659
- By:
- Publication type:
- Article
Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1687, doi. 10.1177/10781552221146801
- By:
- Publication type:
- Article
Value of therapeutic drug monitoring of endoxifen in Egyptian premenopausal patients with breast cancer given tamoxifen adjuvant therapy: A pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1673, doi. 10.1177/10781552221146531
- By:
- Publication type:
- Article
Investigation of the frequency of bortezomib neuropathy in patients with multiple myeloma diagnosis with normal and abnormal genetic characteristics.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1652, doi. 10.1177/10781552221132554
- By:
- Publication type:
- Article
Medication errors in an oncology inpatient setting in India—Audit by clinical pharmacists.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1667, doi. 10.1177/10781552221146529
- By:
- Publication type:
- Article
Tolerability and efficacy of chemoimmunotherapy when administered with a corticosteroid-free anti-emetic regimen.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1661, doi. 10.1177/10781552221146528
- By:
- Publication type:
- Article
Cyclophosphamide exposure via sweat of patients receiving CHOP therapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1646, doi. 10.1177/10781552221145507
- By:
- Publication type:
- Article
Real-world effectiveness of ribociclib in metastatic breast cancer patients: Does dose affect survival?
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1619, doi. 10.1177/10781552221144280
- By:
- Publication type:
- Article
Imatinib plasma levels in patients with gastrointestinal stromal tumour under routine clinical practice conditions.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1613, doi. 10.1177/10781552221143788
- By:
- Publication type:
- Article
Comparing different robots available in the European market for the preparation of injectable chemotherapy and recommendations to users.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1599, doi. 10.1177/10781552221143786
- By:
- Publication type:
- Article
Outpatient initiation of venetoclax in patients with acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1590, doi. 10.1177/10781552221142872
- By:
- Publication type:
- Article
Predictors of community pharmacists' readiness to manage the effective and safe use of oral anticancer medicines in a developing setting.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1580, doi. 10.1177/10781552221141696
- By:
- Publication type:
- Article
Letermovir and tacrolimus interaction effects in hematopoietic cell transplantation recipients receiving moderate cytochrome P450 3A4 inhibitors for antifungal prophylaxis.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1574, doi. 10.1177/10781552221139772
- By:
- Publication type:
- Article
Studies on the optimization of decontamination protocol for surfaces contaminated with cytotoxic drugs in PIVAS.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1565, doi. 10.1177/10781552221138331
- By:
- Publication type:
- Article
Comparison of permeabilities of eight different types of cytotoxic drugs to five gloves with different materials by LC-MS/MS methods to reduce occupational exposure of medical personnel.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 7, p. 1548, doi. 10.1177/10781552221127698
- By:
- Publication type:
- Article